Sales rise 3.89% to Rs 6846.48 crore
Net loss of Sun Pharmaceuticals Industries reported to Rs 108.84 crore in the quarter ended September 2018 as against net profit of Rs 1001.79 crore during the previous quarter ended September 2017. Sales rose 3.89% to Rs 6846.48 crore in the quarter ended September 2018 as against Rs 6590.06 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales6846.486590.06 4 OPM %22.3620.87 -PBDT1752.831473.01 19 PBT1326.321114.36 19 NP-108.841001.79 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
